Salvatore Pisconti
- Cancer Research top 5%
- Cancer Genomics and Diagnostics 12
- Oncology top 5%
- Colorectal Cancer Treatments and Studies 17
- Cancer Treatment and Pharmacology 16
- Cancer Immunotherapy and Biomarkers 6
- HER2/EGFR in Cancer Research 6
-
- Lung Cancer Treatments and Mutations 12
- Renal cell carcinoma treatment 7
- Otorhinolaryngology top 5%
- Reproductive Medicine top 10%
-
- Genetic factors in colorectal cancer 7
- Co-authors
- Giovanni ScambiaDomenica LorussoAnna FagottiAntonella Di StefanoVito CaroneGiuseppina Della Vittoria ScarpatiFrancesco PerriNicola Silvestris
- Journals
- Journal of Clinical Oncology (13 papers)SHILAP Revista de lepidopterología (2 papers)Scientific Reports (1 paper)
- Partner nations
- ItalyUnited StatesGermany
In The Last Decade
Salvatore Pisconti
96 papers receiving 1.6k citations
Peers
Comparison fields: 5 of 104
- Cancer Research 396
- Oncology 692
- Pulmonary and Respiratory Medicine 434
- Otorhinolaryngology 53
- Reproductive Medicine 94
Countries citing papers authored by Salvatore Pisconti
This map shows the geographic impact of Salvatore Pisconti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Salvatore Pisconti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Salvatore Pisconti more than expected).
Fields of papers citing papers by Salvatore Pisconti
This network shows the impact of papers produced by Salvatore Pisconti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Salvatore Pisconti. The network helps show where Salvatore Pisconti may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Salvatore Pisconti, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2024 | 3 | |
| 3 | 2021 | 49 | |
| 4 | Management of Ewing Sarcoma Family of Tumors: A Short Description of a Rare Primitive Uterine pPNET and Literature Review | 2020 | 1 |
| 5 | Pharmacogenomics and Pharmacogenetics: In Silico Prediction of Drug Effects in Treatments for Novel Coronavirus SARS-CoV2 Disease | 2020 | 5 |
| 6 | 2020 | 3 | |
| 7 | 2020 | 4 | |
| 8 | 2019 | 72 | |
| 9 | 2017 | 3 | |
| 10 | 2017 | 28 | |
| 11 | 2016 | 5 | |
| 12 | 2016 | 4 | |
| 13 | 2016 | 14 | |
| 14 | 2015 | 64 | |
| 15 | 2015 | 16 | |
| 16 | 2015 | 56 | |
| 17 | 2015 | 2 | |
| 18 | 2012 | 1 | |
| 19 | 2012 | 9 | |
| 20 | 2010 | 7 |
About Salvatore Pisconti
Salvatore Pisconti is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine, having authored 97 papers that have together received 1.7k indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (17 papers), Cancer Treatment and Pharmacology (16 papers), Cancer Genomics and Diagnostics (12 papers), Lung Cancer Treatments and Mutations (12 papers), Renal cell carcinoma treatment (7 papers), Genetic factors in colorectal cancer (7 papers), Cancer Immunotherapy and Biomarkers (6 papers) and HER2/EGFR in Cancer Research (6 papers). The work is most often cited by research in Cancer Research (396 citations), Oncology (692 citations) and Pulmonary and Respiratory Medicine (434 citations). Salvatore Pisconti has collaborated with scholars based in Italy, United States and Germany. Frequent co-authors include Giovanni Scambia, Domenica Lorusso, Anna Fagotti, Antonella Di Stefano, Vito Carone, Giuseppina Della Vittoria Scarpati, Francesco Perri, Nicola Silvestris, Giuseppe Colucci and Francesco Longo. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.